Shandong Keyuan Pharmaceutical Co. Ltd. A Net Asset Momentum

Latest YoY growth as of December 2024: +2.1%

Shandong Keyuan Pharmaceutical Co. Ltd. A net asset momentum. Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) recorded a net asset momentum of 2.1% as of December 2024, with net assets of CN¥1.36 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how much does Shandong Keyuan Pharmaceutical Co. Ltd. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

YoY Momentum

+2.1%
Year-over-year

Current Net Assets

CN¥1.36 Billion
CNY · December 2024

Years of Data

4
2021 – 2024

Country

China
SHE

Net Asset Momentum of Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)

Net asset momentum of Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024. This chart tracks Shandong Keyuan Pharmaceutical Co. Ltd. A's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +2.1%, with net assets of CN¥1.36 Billion CNY as of December 2024. See Shandong Keyuan Pharmaceutical Co. Ltd. shareholders equity for net asset value and shareholders' equity analysis.

Shandong Keyuan Pharmaceutical Co. Ltd. A Net Asset Momentum by Year (2021–2024)

Shandong Keyuan Pharmaceutical Co. Ltd. A net asset momentum by year from 2021 to 2024. The table below shows the complete annual net asset history for Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Shandong Keyuan Pharmaceutical Co. Ltd. market cap and net worth.

Year Net Assets (CNY) Total Assets Total Liabilities YoY Momentum
2024 CN¥1.36 Billion CN¥1.55 Billion CN¥192.87 Million ▲ +2.1%
2023 CN¥1.33 Billion CN¥1.47 Billion CN¥138.93 Million ▲ +156.1%
2022 CN¥519.73 Million CN¥651.79 Million CN¥132.06 Million ▲ +20.6%
2021 CN¥430.98 Million CN¥559.51 Million CN¥128.52 Million —